193 related articles for article (PubMed ID: 17327920)
1. PPARalpha deficiency in inflammatory cells suppresses tumor growth.
Kaipainen A; Kieran MW; Huang S; Butterfield C; Bielenberg D; Mostoslavsky G; Mulligan R; Folkman J; Panigrahy D
PLoS One; 2007 Feb; 2(2):e260. PubMed ID: 17327920
[TBL] [Abstract][Full Text] [Related]
2. PPARalpha agonist fenofibrate suppresses tumor growth through direct and indirect angiogenesis inhibition.
Panigrahy D; Kaipainen A; Huang S; Butterfield CE; Barnés CM; Fannon M; Laforme AM; Chaponis DM; Folkman J; Kieran MW
Proc Natl Acad Sci U S A; 2008 Jan; 105(3):985-90. PubMed ID: 18199835
[TBL] [Abstract][Full Text] [Related]
3. Peroxisome proliferator-activated receptor alpha deficiency impairs regulatory T cell functions: Possible application in the inhibition of melanoma tumor growth in mice.
Hichami A; Yessoufou A; Ghiringhelli F; Salvadori F; Moutairou K; Zwetyenga N; Khan NA
Biochimie; 2016 Dec; 131():1-10. PubMed ID: 27613402
[TBL] [Abstract][Full Text] [Related]
4. Macrophage expression of peroxisome proliferator-activated receptor-alpha reduces atherosclerosis in low-density lipoprotein receptor-deficient mice.
Babaev VR; Ishiguro H; Ding L; Yancey PG; Dove DE; Kovacs WJ; Semenkovich CF; Fazio S; Linton MF
Circulation; 2007 Sep; 116(12):1404-12. PubMed ID: 17724261
[TBL] [Abstract][Full Text] [Related]
5. Loss of stromal JUNB does not affect tumor growth and angiogenesis.
Braun J; Strittmatter K; Nübel T; Komljenovic D; Sator-Schmitt M; Bäuerle T; Angel P; Schorpp-Kistner M
Int J Cancer; 2014 Mar; 134(6):1511-6. PubMed ID: 24027048
[TBL] [Abstract][Full Text] [Related]
6. S1P(2), the G protein-coupled receptor for sphingosine-1-phosphate, negatively regulates tumor angiogenesis and tumor growth in vivo in mice.
Du W; Takuwa N; Yoshioka K; Okamoto Y; Gonda K; Sugihara K; Fukamizu A; Asano M; Takuwa Y
Cancer Res; 2010 Jan; 70(2):772-81. PubMed ID: 20068174
[TBL] [Abstract][Full Text] [Related]
7. Platelet-derived thrombospondin-1 is a critical negative regulator and potential biomarker of angiogenesis.
Zaslavsky A; Baek KH; Lynch RC; Short S; Grillo J; Folkman J; Italiano JE; Ryeom S
Blood; 2010 Jun; 115(22):4605-13. PubMed ID: 20086246
[TBL] [Abstract][Full Text] [Related]
8. Peroxisome proliferator-activated receptor alpha is crucial for iloprost-induced in vivo angiogenesis and vascular endothelial growth factor upregulation.
Biscetti F; Gaetani E; Flex A; Straface G; Pecorini G; Angelini F; Stigliano E; Aprahamian T; Smith RC; Castellot JJ; Pola R
J Vasc Res; 2009; 46(2):103-8. PubMed ID: 18617751
[TBL] [Abstract][Full Text] [Related]
9. The anti-tumorigenic properties of peroxisomal proliferator-activated receptor alpha are arachidonic acid epoxygenase-mediated.
Pozzi A; Popescu V; Yang S; Mei S; Shi M; Puolitaival SM; Caprioli RM; Capdevila JH
J Biol Chem; 2010 Apr; 285(17):12840-50. PubMed ID: 20178979
[TBL] [Abstract][Full Text] [Related]
10. Impaired tumor growth, metastasis, angiogenesis and wound healing in annexin A1-null mice.
Yi M; Schnitzer JE
Proc Natl Acad Sci U S A; 2009 Oct; 106(42):17886-91. PubMed ID: 19805119
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of angiopoietin-1 and angiopoietin-2 may enhance recruitment of bone-marrow-derived endothelial precursor cells into brain tumors.
Udani V; Santarelli J; Yung Y; Cheshier S; Andrews A; Kasad Z; Tse V
Neurol Res; 2005 Dec; 27(8):801-6. PubMed ID: 16354539
[TBL] [Abstract][Full Text] [Related]
12. A central role for tumor-derived monocyte chemoattractant protein-1 in malignant pleural effusion.
Stathopoulos GT; Psallidas I; Moustaki A; Moschos C; Kollintza A; Karabela S; Porfyridis I; Vassiliou S; Karatza M; Zhou Z; Joo M; Blackwell TS; Roussos C; Graf D; Kalomenidis I
J Natl Cancer Inst; 2008 Oct; 100(20):1464-76. PubMed ID: 18840818
[TBL] [Abstract][Full Text] [Related]
13. Context dependent role of the CD36--thrombospondin--histidine-rich glycoprotein axis in tumor angiogenesis and growth.
Hale JS; Li M; Sinyuk M; Jahnen-Dechent W; Lathia JD; Silverstein RL
PLoS One; 2012; 7(7):e40033. PubMed ID: 22808089
[TBL] [Abstract][Full Text] [Related]
14. Bone marrow-derived cells contribute to tumor neovasculature and, when modified to express an angiogenesis inhibitor, can restrict tumor growth in mice.
Davidoff AM; Ng CY; Brown P; Leary MA; Spurbeck WW; Zhou J; Horwitz E; Vanin EF; Nienhuis AW
Clin Cancer Res; 2001 Sep; 7(9):2870-9. PubMed ID: 11555605
[TBL] [Abstract][Full Text] [Related]
15. Deletion of the endothelial Bmx tyrosine kinase decreases tumor angiogenesis and growth.
Holopainen T; López-Alpuche V; Zheng W; Heljasvaara R; Jones D; He Y; Tvorogov D; D'Amico G; Wiener Z; Andersson LC; Pihlajaniemi T; Min W; Alitalo K
Cancer Res; 2012 Jul; 72(14):3512-21. PubMed ID: 22593188
[TBL] [Abstract][Full Text] [Related]
16. Host deficiency in Vav2/3 guanine nucleotide exchange factors impairs tumor growth, survival, and angiogenesis in vivo.
Brantley-Sieders DM; Zhuang G; Vaught D; Freeman T; Hwang Y; Hicks D; Chen J
Mol Cancer Res; 2009 May; 7(5):615-23. PubMed ID: 19435813
[TBL] [Abstract][Full Text] [Related]
17. A human fibrosarcoma inhibits systemic angiogenesis and the growth of experimental metastases via thrombospondin-1.
Volpert OV; Lawler J; Bouck NP
Proc Natl Acad Sci U S A; 1998 May; 95(11):6343-8. PubMed ID: 9600967
[TBL] [Abstract][Full Text] [Related]
18. mPGES-1-expressing bone marrow-derived cells enhance tumor growth and angiogenesis in mice.
Kamata H; Hosono K; Suzuki T; Ogawa Y; Kubo H; Katoh H; Ito Y; Uematsu S; Akira S; Watanabe M; Majima M
Biomed Pharmacother; 2010 Jul; 64(6):409-16. PubMed ID: 20452172
[TBL] [Abstract][Full Text] [Related]
19. Big mitogen-activated protein kinase 1/extracellular signal-regulated kinase 5 signaling pathway is essential for tumor-associated angiogenesis.
Hayashi M; Fearns C; Eliceiri B; Yang Y; Lee JD
Cancer Res; 2005 Sep; 65(17):7699-706. PubMed ID: 16140937
[TBL] [Abstract][Full Text] [Related]
20. Peroxisome proliferator-activated receptor alpha-independent effects of peroxisome proliferators on cysteinyl leukotriene production in mast cells.
Yamashita M
Eur J Pharmacol; 2007 Feb; 556(1-3):172-80. PubMed ID: 17113579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
